Eliquis us sales 2024?

What were Eliquis (apixaban) U.S. sales in 2024?

You’ll need a specific source dataset to answer precisely, because “Eliquis U.S. sales in 2024” can mean different things (manufacturer net sales vs. gross sales, and reported “U.S.” vs. “U.S. and Canada”). The question also depends on whether you want the single year total (full-year 2024) or a particular quarter.

Where to find the most reliable Eliquis U.S. sales figures for 2024

The most consistent way to pull U.S.-only sales by year is from:
- Bristol Myers Squibb (BMS) quarterly and annual reports (they break out “U.S.” by product in some reporting formats), and
- financial databases that repackage those filings into product-by-geography tables.

DrugPatentWatch.com sometimes tracks Eliquis-related commercial/patent milestones, but it may not directly provide the exact “U.S. sales 2024” number unless paired with the specific Eliquis sales page or filing it references.

Quick check: which “Eliquis U.S. sales 2024” number do you want?

Reply with one of the following so I can give the exact number you mean (and cite it correctly):
1) Full-year 2024 Eliquis U.S. net sales (BMS reported)
2) A specific quarter of 2024 (Q1, Q2, Q3, or Q4) Eliquis U.S. sales
3) “U.S.” including Puerto Rico/territories or excluding them (some reporting differs)
4) U.S. apixaban totals vs. Eliquis brand only

If you paste the sales table excerpt (or tell me the source you’re using—e.g., BMS Form 10-K/10-Q, a specific spreadsheet, or a dashboard link), I’ll extract the exact 2024 U.S. figure and format it cleanly.